VIM and gastric cancer: In gastric cancer, LINC00675 enhanced the phosphorylation of vimentin on Ser83, while in colorectal cancer, LINC00675 inhibited the development of colorectal cancer by sponging miR-942 and regulating Wnt/β-catenin signaling (46, 52).